S S Legha - Concepedia

Author

S S Legha

The University of Texas MD Anderson Cancer Center

Also Known As

S Legha, S S Legha, S. S. LEGHA, S. S. Legha, S.S. Legha, SS Legha, Shubham Legha

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas System

About

S S Legha is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	192
2	Health Sciences	3	3	58
3	Cellular Therapies	1	1	11
4	Clinical Sciences	1	1	29
5	Emergency Medicine	1	1	18

S S Legha

Publications

Citations

H-Index

Page 1

	Year	Citations
Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. S S Legha, Sigrid Ring, Omar Eton, Journal of Clinical Oncology	1998	293
Prognostic factors for survival of patients treated systemically for disseminated melanoma. Omar Eton, S S Legha, T E Moon, Journal of Clinical Oncology	1998	220
Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults S S Legha, MJ Keating, KB McCredie, Blood	1982	104
Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma. Isaiah W. Dimery, S S Legha, Mihran Shirinian, Journal of Clinical Oncology Tumor BiologyOncologyMedicineImmunologyObjective Response Rate	1990	83
The role of interferon alfa in the treatment of metastatic melanoma. S S Legha PubMed	1997	57
Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy. Julie A. Ellerhorst, A. Y. Bedikian, Sigrid Ring, Oncology Reports	1999	49
Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma. Antônio C. Buzaid, S S Legha PubMed	1994	46
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma. Omar Eton, Dmitri D. Kharkevitch, Mary Ann Gianan, PubMed Tumor ImmunologyCancer ImmunosurveillanceActive ImmunotherapyMedicinePhotocarcinogenesis	1998	30
Phase I study of spirogermanium given daily. S S Legha, Jaffer A. Ajani, Gerald P. Bodey Journal of Clinical Oncology Medicinal ChemistryTranslational MedicineMild AnorexiaMedicinePhysiology	1983	29
Initial experience with AMSA as single agent treatment against malignant lymphoproliferative disorders Fernando Cabanillas, S S Legha, GP Bodey, Blood	1981	26

Page 1